Top compounds associated with response to MLYCD


Feature Type Standardized
Nominal ANOVA
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.079 0.06
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.07 0.06
mRNA BRD-K29313308 CTRPv2 pan-cancer AAC 0.071 0.06
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC 0.072 0.06
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.06
mRNA ML311 CTRPv2 pan-cancer AAC -0.062 0.06
mRNA 5-FU CTRPv2 pan-cancer AAC -0.065 0.06
mRNA FQI-2 CTRPv2 pan-cancer AAC -0.061 0.06
mRNA elocalcitol CTRPv2 pan-cancer AAC 0.065 0.06
mRNA isonicotinohydroxamic acid CTRPv2 pan-cancer AAC 0.088 0.06
Download CSV